Cboe Global Markets (CBOE) stock declined 0.90% to $346.06, losing $3.16 during the latest trading session. The shares fell sharply in morning trading before recovering part of the losses. The decline came as the exchange operator announced its support for legal action challenging the Commodity Futures Trading Commission's (CFTC) approval of perpetual derivatives tied to U.S. stocks and exchange-traded funds.

Cboe Joins Legal Challenge Against CFTC Approval

Cboe Global Markets joined the Capital Markets Alliance (CMA) in challenging the CFTC's approval of perpetual derivatives. The alliance also includes Citadel Securities and the Healthy Markets Association. Together, the organizations seek to contest the regulatory basis for allowing these products to trade within CFTC-supervised markets.

The legal action focuses on perpetual derivatives linked to individual U.S. stocks and exchange-traded funds. These contracts allow market participants to gain exposure to underlying securities without directly owning them. Unlike conventional futures, perpetual contracts carry no set expiration date, a structure most widely associated with cryptocurrency trading platforms. Cboe argues, however, that securities-related products should operate under established securities market regulations.

The company maintains that existing securities laws provide specific protections for market participants, and it contends that placing securities products outside registered securities platforms could weaken those safeguards. The legal challenge accordingly seeks to address concerns about regulatory oversight and the treatment of these financial products.

Cboe Raises Concerns Over Securities Market Regulation

According to Cboe Global Markets, the CFTC's recent approvals depart from the regulatory framework governing U.S. securities markets. The company maintains that Congress established specific requirements for securities trading, and it believes regulators should apply those requirements to products linked to individual securities and broader indices.

The exchange operator also raised concerns about regulatory arbitrage across different trading platforms. In its view, offering securities-related products through CFTC-regulated platforms could bypass certain federal and state requirements, weakening established market safeguards and oversight standards.

Cboe additionally emphasized its history of operating within competitive financial markets, noting that the company has more than five decades of experience across global trading markets. It stated that competition and financial innovation do not conflict with its position on regulatory compliance, and it maintains that new products should follow the appropriate legal framework.

Legal Action Could Shape Perpetual Derivatives Oversight

The Capital Markets Alliance is seeking injunctive relief through its legal action against the CFTC's approvals. The request aims to address the uncertainty surrounding the regulator's decisions, and the alliance wants the courts to examine whether these products fall under the appropriate regulatory authority. How the courts respond will shape where these products can trade and under which regulator's framework they operate.

The dispute also raises broader questions about the boundaries between securities and derivatives regulation. The CFTC oversees derivatives markets, while securities trading falls under the Securities and Exchange Commission (SEC) and a separate regulatory framework. Determining which rules apply remains central to the legal challenge.

Cboe Global Markets continues to operate across several major financial market segments, with a business spanning options exchanges, futures trading, equities markets, and clearing services. The regulatory dispute introduces another issue for the company's market position, and Cboe's opposition reflects its stated preference for consistent oversight across securities-related products.

This article is based on reporting originally published by Blockonomi.